<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03576560</url>
  </required_header>
  <id_info>
    <org_study_id>16NE-Z035-6145</org_study_id>
    <nct_id>NCT03576560</nct_id>
  </id_info>
  <brief_title>Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis</brief_title>
  <acronym>Chorio</acronym>
  <official_title>Selective Use of Antibiotics in Neonates Born to Mothers With Suspected Chorioamnionitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mednax Center for Research, Education, Quality and Safety</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mednax Center for Research, Education, Quality and Safety</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Retrospective Chart Review to determine the selective use of antibiotics in neonates born to
      mothers with suspected chorioamnionitis
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To determine the incidence and types of adverse outcomes in infants born to mothers with
      signs of chorioamnionitis when these infants are asymptomatic and are not treated with
      antibiotics empirically.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 26, 2017</start_date>
  <completion_date type="Actual">May 1, 2019</completion_date>
  <primary_completion_date type="Actual">March 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Infants born to mother with chorioamnionitis/intrapartum fever as assessed by chart review.</measure>
    <time_frame>Infants born from July, 2012 to December 31, 2018.</time_frame>
    <description>The retrospective chart review would analyze the total number of infants born to mothers with chorioamnionitis/intrapartum fever.</description>
  </primary_outcome>
  <enrollment type="Actual">768</enrollment>
  <condition>Chorioamnionitis</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Retrospective Chart Review</intervention_name>
    <description>Retrospective Chart Review</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients born at Women's Hospital/Cone Health in Greensboro, NC, from July, 2012 (when EMR
        was implemented), to present.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Mother/baby dyads in which the mother was diagnosed with chorioamnionitis and/or had
        intrapartum fever (as diagnosed by obstetrician)

        Exclusion Criteria: None
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Mother/baby in which the mother was diagnosed with chorioamnionitis and/or had intrapartum fever</gender_description>
    <minimum_age>35 Weeks</minimum_age>
    <maximum_age>42 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Wimmer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MEDNAX Employee</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Women's Hospital of Greensboro</name>
      <address>
        <city>Greensboro</city>
        <state>North Carolina</state>
        <zip>27408-7079</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>June 26, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 3, 2018</study_first_posted>
  <last_update_submitted>June 20, 2019</last_update_submitted>
  <last_update_submitted_qc>June 20, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chorioamnionitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

